Latest
Hot
Columns New Share Pricing | China Hong Kong Holdings wins 2.21 times bid, priced at HK$5.36 per share
Futu News July 11, This Week $SINOHEALTH TECH (02361.HK)$The announcement was made that the company issued 7500 million shares at a price of HK$5.36 per share and 500 shares per share and is expected to be listed on July 12.
During the IPO period, Kang Holdings acquired a 2.21 multiplier purchase and the final number of shares allocated to the public offering was 750 million shares, representing approximately 10% of the total shares sold (prior to the exercise of any superannuation rights). A total of 4352 valid applications were received, and the participation rate was 50.02%.
Outside of this, the Company has sold a superannuation, with a maximum target of 6750 shares, equivalent to about 90% of the sold shares (before any superannuation is implemented. The Futu Constraint Sort is related to the following:
CITIC HOLDINGS PRIMARILY PROVIDES HEALTH INSIGHT SOLUTIONS TO ADDRESS THE SALES AND MARKETING NEEDS OF MEDICAL PRODUCT MANUFACTURER CUSTOMERS. These solutions are mainly based on the company's retail data, while retail data makes up the bulk of the company's healthy big data.
Since 2008, the company has been committed to driving the digital transformation of China's health industry. Driven by big data and technology, the company has been developing comprehensive health big data solutions for health industry participants, primarily providing market-driven end-to-end solutions for the sales and marketing functions of medical product manufacturer customers. and products.
The company is a leader in the medical products and channels division. According to Airy Consulting's report, according to 2021...
During the IPO period, Kang Holdings acquired a 2.21 multiplier purchase and the final number of shares allocated to the public offering was 750 million shares, representing approximately 10% of the total shares sold (prior to the exercise of any superannuation rights). A total of 4352 valid applications were received, and the participation rate was 50.02%.
Outside of this, the Company has sold a superannuation, with a maximum target of 6750 shares, equivalent to about 90% of the sold shares (before any superannuation is implemented. The Futu Constraint Sort is related to the following:
CITIC HOLDINGS PRIMARILY PROVIDES HEALTH INSIGHT SOLUTIONS TO ADDRESS THE SALES AND MARKETING NEEDS OF MEDICAL PRODUCT MANUFACTURER CUSTOMERS. These solutions are mainly based on the company's retail data, while retail data makes up the bulk of the company's healthy big data.
Since 2008, the company has been committed to driving the digital transformation of China's health industry. Driven by big data and technology, the company has been developing comprehensive health big data solutions for health industry participants, primarily providing market-driven end-to-end solutions for the sales and marketing functions of medical product manufacturer customers. and products.
The company is a leader in the medical products and channels division. According to Airy Consulting's report, according to 2021...


+1
6
1
10
Unlock Pro Investors’ Money-Making Secrets
Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives